Targeted temperature management has become a mainstay of treatment for resuscitated patients following cardiac arrest.

Manoj Saxena is an intensivist and clinician researcher from Sydney, Australia, and was part of the team that delivered the TTM-2 trial earlier in 2021.  He joins Todd on the podcast to discuss the premise of TTM-2, the results and what comes next.

See omnystudio.com/listener for privacy information.